Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ju, NJ
Gang Ju, Fairlawn, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080300550 | POSITIVE DISPLACEMENT STOPPER FOR A PRE-FILLED SYRINGE - A stopper adapted for attachment with a plunger rod for use within a syringe barrel is disclosed. The stopper includes a main body defining an open rearward end and a closed front end. The open rearward end is adapted to receive a front forward end attachment portion of the plunger rod. The stopper also includes a core member integrally formed with said main body adjacent the closed front end. The core member includes a nose portion having a profile adapted to create a positive seal with an outlet opening of such syringe barrel. | 12-04-2008 |
| 20080300551 | STOPPER AND PLUNGER ROD FOR A PRE-FILLED SYRINGE - A plunger rod adapted for attachment with a stopper for use with a syringe barrel is disclosed. The plunger rod includes an elongated member having a front end and a back end, the plunger rod extending along a longitudinal axis. The plunger rod includes at least one deflecting arm associated with the front end of the elongated member. The deflecting arm is capable of deflecting radially inward during insertion of the plunger rod into a stopper, and deflecting outward into contact with an inner surface of the stopper after insertion to lock the plunger rod within the stopper. | 12-04-2008 |
Gang Ju, Fair Lawn, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110034882 | Stoppers Used in Pre-filled Syringes - A stopper adapted for attachment with a plunger rod for use within a syringe barrel is disclosed. The stopper includes a main body defining an open rearward end and a closed front end. The open rearward end is adapted to receive a front forward end attachment portion of the plunger rod. The stopper also includes a core member integrally formed with the main body adjacent the closed front end. The core member includes a nose portion having a conical tip configured for entering an outlet opening of the syringe barrel. The closed front end of the stopper has a profile configured to cooperate with an internal surface of the syringe barrel wall to prevent reflux and reduce dead space within the barrel. | 02-10-2011 |
Gang Ju, Wyckoff, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090208923 | System and method for diagnosing diseases - One aspect of the invention provides a method of diagnosing a disease condition, comprising measuring presence or amount of a targeted protein or a degradation product of said protein in a collected biological sample as a marker for the disease condition. The targeted protein or degradation product is selected for measurement based on a prior identification of a measurable half-life at a predetermined time period, including the time at which said method is conducted, and correlating said measuring with the presence or absence of the disease condition. The targeted protein or degradation product may be identified by selecting a protein known or suspected to be a diagnostic marker for the disease condition, analyzing degradation of the protein in the collected biological sample, and selecting a protein or degradation product that exhibits a measurable half-life at a predetermined period of time. The analyzing may include identifying degradation product(s) of the protein as a function of time, and half-life of the protein and the degradation product(s). | 08-20-2009 |
Grace Ju, Montclair, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110152349 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES - The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a IL-18 gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of a IL-18 gene using said pharmaceutical composition; and methods for inhibiting the expression of IL-18 in a cell. | 06-23-2011 |
Jingyue Ju, Englewood Clffs, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100092952 | FOUR-COLOR DNA SEQUENCING BY SYNTHESIS USING CLEAVABLE FLUORESCENT NUCLEOTIDE REVERSIBLE TERMINATORS - This invention provides a process for sequencing single-stranded DNA by employing a nanopore and modified nucleotides. | 04-15-2010 |
Wen-Hua Ju, Monmouth Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090245493 | System and Method for Displaying Call Flows and Call Statistics - The system and method identify a plurality of call flow events in a call analysis system. Call statistics are associated with the call flow events. The call flow events are organized into event groups each containing a plurality of call flow events. Once an event group is selected, call statistics for the events of the event group are displayed. In addition, the system and method allow for selection of individual call flow events in order to display calls associated with the events. | 10-01-2009 |
Yiguang Ju, Pennington, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090121189 | SYNTHESIS OF BIO-FUNCTIONALIZED RARE EARTH DOPED UPCONVERTING NANOPHOSPHORS - Methods for preparing rare earth doped monodisperse, hexagonal phase upconverting nanophosphors, the steps of which include: | 05-14-2009 |
| 20100124658 | METHOD FOR SYNTHESIZING PHOSPHORESCENT OXIDE NANOPARTICLES - A method for producing activated substantially monodisperse, phosphorescent oxide particles with rare earth element dopants uniformly dispersed therein by mixing a rare earth element dopant precursor powder with an oxide-forming host metal powder to form a solid-phase precursor composition; vaporizing the solid-phase precursor composition; combining the vaporized precursor with an inert carrier gas; contacting the inert carrier gas and the vaporized precursor with a flame fueled by a reactive gas; and uniformly heating the vaporized precursor in the flame to a reaction temperature sufficient to form activated phosphorescent oxide nanoparticles. | 05-20-2010 |